results

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022

– STP0404 is the only HIV treatment candidate that has been proven safe and has a novel mechanism capable of blocking HIV reactivation. – STP0404 is expected to enter a Phase 2a clinical trial in the United States in the fourth quarter of 2022. SEOUL, South Korea, August 3, 2022 /PRNewswire/ — ST Pharm Co., …

ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022 Read More »

For tech, the euphoria of the pandemic is over

For tech, the euphoria of the pandemic is over

Amazon and Apple reassured the market somewhat on Thursday with better-than-expected sales, after many disappointing performances from other tech companies battling the economic downturn. The e-commerce giant made more than $121 billion in revenue in the second quarter, up 7%, despite an unfavorable comparison with last year. Its stock jumped more than 10% in electronic …

For tech, the euphoria of the pandemic is over Read More »